Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results.
Rikke Lind JørgensenChristian Johann LercheMartin Schou PedersenNikolai Soren KirkbyAmanda Bolt BotnenRamona TrebbienStephen Nilsson-MøllerMette PinholtAlex Christian Yde NielsenHenrik WesthJan Gorm LisbyUffe Vest SchneiderPublished in: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (2022)
In March 2022, we observed samples with a negative fluorescent signal (60.5%, n = 43) for the influenza A matrix gene and a stronger positive signal for subtype A(H3N2). Forty-three samples were positive in InfA (H3N2) (mean Cq 30.9, range 23.9-35.1), and 26 of the 43 samples were negative in InfA matrix (mean Cq 28.0, range 23.2-30.6). Our multiplex test is a laboratory-developed four-target, four-color influenza A reverse-transcription PCR assay targeting the matrix gene, subtypes A(H3N2) and A(H1N1)pdm09. Several samples were negative when retested on commercial influenza Point-of-Care assays. As the matrix gene is a stand-alone target in most commercial diagnostic assays, we caution against false-negative subtype A test results.